These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 239225)

  • 21. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release.
    Robitaille R; Tremblay JP
    Neuroscience; 1991; 40(2):571-85. PubMed ID: 1674115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in miniature end-plate currents due to high potassium and calcium at the frog neuromuscular junction.
    Glavinović MI
    Synapse; 1988; 2(6):636-43. PubMed ID: 3264941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On potassium functional feedback in neuromuscular junction.
    Matyushkin DP; Shabunova IA; Sharovarova GM; Vinogradova IM
    J Neurosci Res; 1978; 3(5-6):441-50. PubMed ID: 216816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endotoxin alters spontaneous transmitter release at the frog neuromuscular junction.
    Person RJ
    J Neurosci Res; 1977; 3(1):63-72. PubMed ID: 23437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The action of the sodium ionophore, monensin, or transmitter release at the frog neuromuscular junction.
    Meiri H; Erulkar SD; Lerman T; Rahamimoff R
    Brain Res; 1981 Jan; 204(1):204-8. PubMed ID: 6113873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increase in spontaneous transmitter release produced by beta-bungarotoxin and its modification by inorganic ions.
    Alderdice MT; Volle RL
    J Pharmacol Exp Ther; 1978 Apr; 205(1):58-68. PubMed ID: 24734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the effect of calcium on the frequency of miniature end-plate potentials at the frog neuromuscular junction.
    Matthews G; Wickelgren WO
    J Physiol; 1977 Mar; 266(1):91-101. PubMed ID: 192883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM; van den Bercken J; van der Zalm J
    Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of intracellular Ca2+ in stimulation-induced increases in transmitter release at the frog neuromuscular junction.
    Zengel JE; Sosa MA; Poage RE; Mosier DR
    J Gen Physiol; 1994 Aug; 104(2):337-55. PubMed ID: 7807052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tetanic potentiation of miniature end-plate potential frequency at frog neuromuscular junction in manganese solutions].
    Narita K
    Nihon Seirigaku Zasshi; 1985; 47(12):746-55. PubMed ID: 3007749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equivalence of Ca2+ and Sr2+ in transmitter release from K+-depolarised nerve terminals.
    Mellow AM
    Nature; 1979 Nov; 282(5734):84-5. PubMed ID: 41184
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lindane upon transmitter release and end-plate responsiveness in the neuromuscular junction of the frog.
    Joy RM; Vogel SM; Narahashi T
    Neuropharmacology; 1987 Aug; 26(8):1223-9. PubMed ID: 2443872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of transmitter release by presynaptic and glial Ca2+ internal stores at the neuromuscular synapse.
    Castonguay A; Robitaille R
    J Neurosci; 2001 Mar; 21(6):1911-22. PubMed ID: 11245676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrahydroaminoacridine and physostigmine have opposing effects on probability of transmitter release at the frog neuromuscular junction.
    Provan SD; Miyamoto MD
    Neurosci Lett; 1991 Feb; 123(1):127-30. PubMed ID: 1676497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of omega-conotoxin GVIA on neurotransmitter release at the mouse neuromuscular junction.
    Protti DA; Szczupak L; Scornik FS; Uchitel OD
    Brain Res; 1991 Aug; 557(1-2):336-9. PubMed ID: 1684129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.